Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Program letter encourages public health partners and grant recipients to implement status neutral approaches to HIV care and prevention.News Article updated on 01/18/2023
-
Ryan White Conference Database Expands
A searchable database is now available to access slides and videos from HRSA Ryan White Conferences stretching back to 2020.Blog updated 03/28/2024
-
Write about Your HIV Intervention with Confidence
Not sure how to tackle the task of writing about your intervention? IHIP can help.News Article updated on 01/27/2023 -
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
-
RWHAP Part A Guidance for Planning Bodies on Supporting People with Lived Experience
From the HRSA HIV/AIDS Bureau Listserv, 12/16/22
News Article updated on 12/19/2022 -
Imposition of Charges Schedule of Charges and Cap on Charges
RWHAP statutory requirements and programmatic guidance pertaining to the imposition of charges on clients for services, the schedule of charges, nominal charges, sliding fee scale, and caps on charges.Resource (Conference Presentation) updated 09/14/2023
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Investigating Needs and Scale-Up Costs for RWHAP-Funded Support Services: Food, Financial, Transportation, and Housing
We conducted semi-structured interviews with service providers to investigate current barriers, potential opportunities, estimated costs, and anticipated outcomes of program expansion for food, financial, transportation, and housing support services for RWHAP clients.
Resource (Conference Presentation) updated 09/14/2023
-
Development of a Community Planning and Budget Allocation Tool to Reduce HIV Outcome Disparities
We used a data-driven, mixed method approach to develop a community planning and budget tool to inform resource allocation decision-making to achieve health equity in HIV outcomes among RWHAP clients in the Minneapolis-St. Paul Transitional Grant Area.
Resource (Conference Presentation) updated 09/14/2023
-
Promising Practices: The Impact of COVID-19 Related Policy Changes On Enrollment Capacity Within California's ADAP
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
-
Maintaining housing stability among PWH in the NY EMA during COVID-19
The COVID-19 public health emergency (PHE) exacerbated homelessness and housing instability. NY EMA Planning staff worked collaboratively to address homelessness as a driving force of poorer health outcomes for people living with HIV. This presentation will illustrate community planning processes for addressing housing-related barriers among RWHAP consumers during the PHE.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Community Co-Creation: Engaging Traditional and Nontraditional Partners in a National Viral Suppression Campaign
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023
-
California Department of Public Health Implementation Blueprint
Adaptable implementation blueprint to accompany the Integrated HIV Prevention and Care Plan, designed to make the plan actionable and relevant at the local level. Developed by the California Department of Public Health.Resource updated 10/11/2023
-
RWHAP Part B Supplemental PTR Manual
Instructions on how (RWHAP Part B Supplemental recipients can access, complete, and submit the RWHAP Part B Supplemental Program Terms Report (PTR).Resource updated 06/27/2024
-
Non-Competing Continuation RWHAP Part B/ADAP (X07): FY24 NCC Progress Report Submission
Instructions and resources for completing and submitting the FY 2024 Ryan White HIV/AIDS Program (RWHAP) Part B Non-Competing Continuation Progress Report.Resource updated 10/10/2023
-
RWHAP Program Letter: ADAPs and SUD Medications
On May 11, HRSA’s HIV/AIDS Bureau released a program letter encouraging RWHAP ADAP recipients to include medications for SUDs, including buprenorphine for OUD, and naloxone for opioid overdose prevention, on ADAP formularies.News Article updated on 05/15/2023 -
Program Letter: Role of RWHAP in Addressing STIs and Mpox
State AIDS Drug Assistance Programs (ADAPs), which provide medications for people with HIV who lack health coverage. play "a critical role in addressing STIs for people with HIV"News Article updated on 05/24/2023 -
Long-Acting Injectables for HIV Antiretroviral Therapy
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.Resource updated 04/12/2024